|
1
|
Turdean S, Gurzu S, Turcu M, Voidăzan S
and Sin A: Liver metastases: Incidence and clinicopathological
data. Acta Medica Marisiensis. 58:254–258. 2012.
|
|
2
|
Tarasik A, Jaroszewicz J and Januszkiewicz
M: Surgical treatment of liver tumors - own experience and
literature review. Clin Exp Hepatol. 3:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Swaid F, Downs D and Rosemurgy AS: A
practical approach to liver metastasis from unknown primary cancer:
What surgeons need to know. Cancer Genet. 209:559–566. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hijazi H, Campeau MP, Roberge D, Donath D,
Lapointe R, Vanderbroucke-Menu F, Taussky D, Boudam K, Chan G,
Bujold A and Delouya G: Stereotactic body radiotherapy for
inoperable liver tumors: Results of a single institutional
experience. Cureus. 8:e9352016.PubMed/NCBI
|
|
5
|
de Baere T, Tselikas L, Yevich S, Boige V,
Deschamps F, Ducreux M, Goere MD, Nguyen F and Malka D: The role of
image-guided therapy in the management of colorectal cancer
metastatic disease. Eur J Cancer. 75:231–242. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kennedy AS: Radiation oncology approaches
in liver malignancies. Am Soc Clin Oncol Educ Book. e150–e155.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dawood O, Mahadevan A and Goodman KA:
Stereotactic body radiation therapy for liver metastases. Eur J
Cancer. 45:2947–2959. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brethsneider T, Ricke J, Gebauer B and
Streitparth F: Image-guided high dose rate brachytherapy of
malignances in various organs-technique, indications and
perspectives. J Contemp Brachytherapy. 8:251–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kordzińska-Cisek I, Brzozowska A, Cisek P,
Kijek J and Mazurkiewicz M: The role of radiotherapy in the
treatment of hepatic neoplasms. Oncol Radiother. 36:53–60.
2016.
|
|
10
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Picot J, Cooper K, Bryant J and Clegg AJ:
The clinical effectiveness and cost-effectiveness of Bortezomib and
thalidomide in combination regimens with an alkylating agent and a
corticosteroid for the first-line treatment of multiple myeloma: A
systematic review and economic evaluation. Health Technol Assess.
15:1–204. 2011. View
Article : Google Scholar
|
|
12
|
Marinello G and Pierquin B: The Paris
system, optimization of dose, and calculation of treatment timeA
practical manual of Brachytherapy. Medical Physics Publishing;
Madison, WI: pp. 53–68. 1997
|
|
13
|
Ricke J, Wust P, Wieners G, Beck A, Cho C,
Seidensicker M, Pech M, Werk M, Rosner C, Hänninen EL, et al: Liver
malignancies: CT-guided interstitial brachytherapy in patients with
unfavorable lesions for thermal ablation. J Vasc Interv Radiol.
15:1279–1286. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
U.S. Department Of Health And Human
Services, . National Institutes of Health, National Cancer
Institute: Common Terminology Criteria for Adverse Events (CTCAE).
Version v4.03. http://www.oncology.tv/SymptomManagement/NationalCancerInstituteUpdatesCTCAEtov403.aspxJune
14–2010
|
|
15
|
Cisek P, Kordzińska-Cisek I, Charkot Ł,
Korona P, Kieszko D, Bilski M, Brzozowska A, Janiszewski M and
Grzybowska-Szatkowska L: Biochemical liver function markers after
CT-guided brachytherapy for liver metastases. Oncol Radiotherap.
39:67–75. 2017.
|
|
16
|
Ricke J, Mohnike K, Pech M, Seidensticker
M, Rühl R, Wieners G, Gaffke G, Kropf S, Felix R and Wust P: Local
response and impact on survival after local ablation of liver
metastases from colorectal carcinoma by computed tomography-guided
high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys.
78:479–485. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mohnike K, Wieners G, Pech M,
Seidensticker M, Rühl R, Lopez-Haenninen E and Ricke J:
Image-guided interstitial high-dose-rate brachytherapy in
hepatocellular carcinoma. Dig Dis. 27:170–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wieners G, Mohnike K, Peters N, Bischoff
J, Kleine-Tebbe A, Seidensticker R, Seidensticker M, Gademann G,
Wust P, Pech M and Ricke J: Treatment of hepatic metastases of
breast cancer with CT-guided interstitial brachytherapy-a phase
II-study. Radiother Oncol. 100:314–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wieners G, Schippers AC, Collettini F,
Schnapauff D, Hamm B and Gebauer B: CT-guided high-dose-rate
brachytherapy in the interdisciplinary treatment of patients with
liver metastases of pancreatic cancer. Hepatobiliary Pancreat Dis
Int. 14:530–538. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schippers AC, Collettini F, Steffen IG,
Wieners G, Denecke T, Pavel M, Wust P and Gebauer B: Initial
experience with CT-guided high-dose-rate brachytherapy in the
multimodality treatment of neuroendocrine tumor liver metastases. J
Vasc Interv Radiol. 28:672–682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bretschneider T, Mohnike K, Hass P,
Seidensticker R, Göppner D, Dudeck O, Streipath F and Ricke J:
Efficacy and safety of image-guided interstitial single fraction
high-dose-rate brachytherapy in the management of metastatic
malignant melanoma. J Contemp Brachytherapy. 7:154–160. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ricke J and Wust P: Computed
tomography-guided brachytherapy for liver cancer. Semin Radiat
Oncol. 24:287–293. 2011. View Article : Google Scholar
|
|
23
|
Mohnike K, Wieners G, Schwartz F,
Seidensticker M, Pech M, Ruehl R, Wust P, Lopez-Hänninen E,
Gademann G, Peters N, et al: Computed tomography-guided
high-dose-rate brachytherapy in hepatocellular carcinoma: Safety,
efficacy, and effect on survival. Int J Radiat Oncol Biol Phys.
78:172–179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Geisel D, Denecke T, Collettini F, Grieser
C, Wust P, Thuss-Patence P, Hamm B and Gebaueret B: Treatment of
hepatic metastases from gastric or gastroesophageal adenocarcinoma
with computed tomography-guided high-dose-rate brachytherapy
(CT-HDRBT). Anticancer Res. 32:5453–5458. 2012.PubMed/NCBI
|
|
25
|
Geisel D, Collettini F, Denecke T, Grieser
C, Flörcken A, Wust P, Hamm B and Gebaueret B: Treatment for liver
metastasis from renal cell carcinoma with
computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT):
A case series. World J Urol. 31:1525–1530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sharma DN, Thulkar S, Sharma S, Gandhi AK,
Haresh KP, Gupta S, Rath GK and Julka PK: High-dose-rate
interstitial brachytherapy for liver metastases: First study from
India. J Contemp Brachytherapy. 5:70–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joo JH, Park JH, Kim JC, Yu CS, Lim SB,
Park IJ, Kim TW, Hong YS, Kim KP and Yoon SM: Local control
outcomes using stereotactic body radiation therapy for liver
metastases from colorectal cancer. Int J Radiat Oncol Biol Phys.
99:876–883. 2017. View Article : Google Scholar : PubMed/NCBI
|
